Team:Goettingen/Team/DAC

From 2013.igem.org

(Difference between revisions)
Line 51: Line 51:
<html><img src="https://static.igem.org/mediawiki/2013/5/51/Goe-greenColi-labcoat.png" style="height: 200px;position: absolute;top: 1347px;left: 361px;" /></html>
<html><img src="https://static.igem.org/mediawiki/2013/5/51/Goe-greenColi-labcoat.png" style="height: 200px;position: absolute;top: 1347px;left: 361px;" /></html>
<html><img src="https://static.igem.org/mediawiki/2013/6/6e/Goe-greenColi-crystal.png" style="position: absolute;top: 3565px;left: 500px;z-index: 3;" /></html>
<html><img src="https://static.igem.org/mediawiki/2013/6/6e/Goe-greenColi-crystal.png" style="position: absolute;top: 3565px;left: 500px;z-index: 3;" /></html>
-
As the cloning of the full-length (273 aa) membrane-bound DAC, DacA (Lmo2120) using ''Escherichia coli'' failed, we decided to clone a truncated ''dacA'' gene, that encodes a truncated DAC protein, lacking the trans-membrane domain. In this protein the first 100 amino acids are missing. Nevertheless, the resulting truncated part still included the essential DAC domain, and therefore represents one of our favorite BioBricks: [http://parts.igem.org/Part:BBa_K1045003 BBa_K1045003]!
+
Unfortunately, cloning of the full-length gene, encoding the membrane-bound DAC, DacA (Lmo2120) using ''Escherichia coli'' failed. Therefore, we decided to clone a truncated ''dacA'' gene, that encodes a DAC enzyme, lacking the trans-membrane domain. In this protein the first 100 amino acids are missing. Nevertheless, the resulting truncated part still included the essential DAC domain, and therefore represents one of our favorite BioBricks: [http://parts.igem.org/Part:BBa_K1045003 BBa_K1045003]!
-
By conducting several experiments, we proved that the truncated DacA protein (BBa_K1045003) was not only active ''in vivo'', but also ''in vitro''. Moreover, we were able to purify the diadenylate cyclase in large scale for determining its 3D structure! Using the structure data, one can now search for chemical compounds that interfere with the activity of the cyclase either by testing with available chemical libraries or by computational modeling. In the following text, the experiments will be explained in more detail.  However, if you wish to get even more details, please visit the [[Team:Goettingen/Parts|Parts Registry]] or [[Team:Goettingen/NoteBook|our LabBook.]]
+
By conducting several experiments, we proved that the truncated DacA protein (BBa_K1045003) was not only active ''in vivo'', but also did it's job ''in vitro''. Moreover, we were able to purify the diadenylate cyclase in large scale for determining its 3D structure! Using the structure data, one can now search for chemical compounds that interfere with the activity of the cyclase either by testing with available chemical libraries or by computational modeling. In the following text, the experiments will be explained in more detail.  However, if you wish to get even more details, please visit the [[Team:Goettingen/Parts|Parts Registry]] or [[Team:Goettingen/NoteBook|our LabBook.]]
The truncated DacA protein ([http://parts.igem.org/Part:BBa_K1045003 BBa_K1045003]) was extended with an N-terminal Step-tag allowing easy purification steps. The expression of our protein was brought under the control of a T7 promoter, enabling us to induce the expression by addition of Isopropyl-β-D-thiogalactopyranoside (IPTG). The plasmid was then cloned into the ''E. coli'' strain BL21, which is a protein expression strain. The Gram-negative bacterium ''E. coli'' does not produce c-di-AMP and is not severely affected by the signaling molecule in contrast to Gram-positive bacteria.
The truncated DacA protein ([http://parts.igem.org/Part:BBa_K1045003 BBa_K1045003]) was extended with an N-terminal Step-tag allowing easy purification steps. The expression of our protein was brought under the control of a T7 promoter, enabling us to induce the expression by addition of Isopropyl-β-D-thiogalactopyranoside (IPTG). The plasmid was then cloned into the ''E. coli'' strain BL21, which is a protein expression strain. The Gram-negative bacterium ''E. coli'' does not produce c-di-AMP and is not severely affected by the signaling molecule in contrast to Gram-positive bacteria.

Revision as of 18:54, 27 October 2013





The beast and its Achilles heel:

 A novel target to fight multi-resistant pathogenic bacteria



DAC Team

Introduction

In order to find a target that can be inhibited by new antibacterial compounds, we focused on the recently discovered signaling molecule bis-(3’,5’)-cyclic dimeric adenosine monophosphate (c-di-AMP). c-di-AMP was shown to be an essential second messenger in many important pathogenic Gram-positive bacteria (Witte et al., 2008). Moreover, c-di-AMP has a crucial function in cell wall synthesis and spore formation in Bacillus subtilis (Oppenheimer-Shaanan et al., 2011; Mehne et al., 2013). Interestingly, both lack and excess of c-di-AMP have detrimental effects on cell growth and morphology (Luo and Helmann, 2012; Mehne et al., 2013).

Based on these observations, it makes sense that we take a closer look at the enzyme, the diadenylate cyclase (DAC), which produces c-di-AMP. The DAC CdaA is conserved among several Gram-positive bacteria like B. subtilis, and the important pathogenic bacteria Streptococcus pneumoniae, Staphylococcus aureus and Listeria monocytogenes (Corrigan and Gründling, 2013). So far, the DAC DisA from B. subtilis has been purified and crystallized (Witte et al., 2008). However, this protein is not present in all Gram-positive bacteria as well as in many pathogenic bacteria. Therefore we decided to concentrate on the DAC CdaA from L. monocytogenes, which is - as mentioned above - well-conserved in all bacteria that need c-di-AMP for growth!

Results and Discussion

Unfortunately, cloning of the full-length gene, encoding the membrane-bound DAC, DacA (Lmo2120) using Escherichia coli failed. Therefore, we decided to clone a truncated dacA gene, that encodes a DAC enzyme, lacking the trans-membrane domain. In this protein the first 100 amino acids are missing. Nevertheless, the resulting truncated part still included the essential DAC domain, and therefore represents one of our favorite BioBricks: BBa_K1045003!

By conducting several experiments, we proved that the truncated DacA protein (BBa_K1045003) was not only active in vivo, but also did it's job in vitro. Moreover, we were able to purify the diadenylate cyclase in large scale for determining its 3D structure! Using the structure data, one can now search for chemical compounds that interfere with the activity of the cyclase either by testing with available chemical libraries or by computational modeling. In the following text, the experiments will be explained in more detail. However, if you wish to get even more details, please visit the Parts Registry or our LabBook.

The truncated DacA protein (BBa_K1045003) was extended with an N-terminal Step-tag allowing easy purification steps. The expression of our protein was brought under the control of a T7 promoter, enabling us to induce the expression by addition of Isopropyl-β-D-thiogalactopyranoside (IPTG). The plasmid was then cloned into the E. coli strain BL21, which is a protein expression strain. The Gram-negative bacterium E. coli does not produce c-di-AMP and is not severely affected by the signaling molecule in contrast to Gram-positive bacteria.

In order to analyze the cyclase activity in vivo, the E. coli clones were induced to express the protein by the addition of IPTG. The cells were then lysed to extract c-di-AMP from the cells.

By performing the SDS gel electrophoresis it was nicely shown that the desired protein was highly expressed (Fig. 1). Furthermore, the presence of c-di-AMP in the supernatant of the lysed bacteria was confirmed using LC-MS/MS. Thus, one can conclude that our truncated DacA protein codes for an active adenylate cyclase domain in vivo.

Goe-dac-fig-1.png

Fig. 1. Confirmation of the high expression of DacA. The SDS gel electrophoresis confirmed the high expression of DacA Lmo2120 in three biological replicates showing a thick band at about 20 kDa; Lane 1: Thermo Scientific Page Ruler Plus Prestained Protein Ladder.


Diadenylate cyclases catalyze the condensation reaction of two molecules of ATP to a single molecule c-di-AMP, while releasing two pyrophosphate molecules consisting of the β-γ-phosphates of each ATP (Fig. 2). In order to analyze the cyclase activity of DacA in vitro, we performed an assay in which these pyrophosphate molecules were used as evidence for the reaction. Among other things, the assay included a pyrophosphatase that cleaves the pyrophosphate molecule into free phosphate molecules, malachite-green and molybdate. Malachite-green forms a complex with free phosphate molecules and molybdate stabilizes the complex. The product absorption can be measured at 630 nm. With this in vitro assay, the concentration of free phosphate molecules and thus the conversion rate of ATP to c-di-AMP was analyzed.

Our results confirmed that DacA Lmo2120 acts as an active enzyme in the presence of a divalent cation, ATP and a buffer system at pH 8 (in vitro), however, the catalysis rate in vivo appears to be much more efficient.

Fig. 2. Cyclic di-AMP production and degradation. Cyclic di-AMP is produced from two molecules of ATP by diadenylyl cyclase (DAC) enzymes and degraded to pApA by phosphodiasterases. (Edited from Corrigan and Gründling, 2013)


Finally, we are coming to the core of our project, the protein structure of DacA! The molecular structure of DacA is very beneficial to have as it makes in silico experiments possible, which can lead to the discovery of new antibacterial substance classes that later can be used to treat patients.

In order to purify a large amount of this protein, our BioBrick BBa_K1045003 with an N-terminal Strep-tag was expressed in E. coli under the control of a T7 promoter. The expression was again induced by supplementing the growth medium with IPTG. The high expression was confirmed by SDS gel electrophoresis with a resulting thick band at the size of approximately 20 kDa (Fig. 3). The E. coli strain was grown in large scale (10 liters), the cells were pelletized, lysed and the protein was purified (Fig. 3).

Fig. 3. SDS gel showing overexpression and purification of DacA. (A) Lane 1: Thermo Scientific PageRuler Plus Prestained Protein Ladder; NI: Non-induced, Clone contained the cyclase domain of which the activity was not induced; I: Induced, Clone contained the cyclase domain of which the activity was induced by addition of isopropyl-ß-D-1-thiogalactopyranoside (IPTG); L: Lysate; FT: Flow-through; After wash 1 our protein was purified.

Having dialyzed and concentrated the eluted protein, we obtained a protein concentration of about 10 mg/ml, which was sufficient to perform the crystallization reaction. Very nice crystals were obtained during trials when testing with different conditions (Fig. 4A). In order to find the perfect supplements for growing our crystals, the whole procedure was repeated. The crystals yielded an x-ray diffraction pattern, with a resolution of 2,8 Å (Fig. 4B,C). The dataset was measured at the EMBL Hamburg Beamline P13 at the PETRA III synchrotron on the DESY campus, using a PILATUS2 6M X-ray detector (https://www.dectris.com/).

Finally, we were also able to obtain the protein structure (Fig. 5)! The structure shows a globular protein with a distinct ATP-binding cleft. The ribbon model demonstrates the secondary structure composed of α-helices and β-sheets.

Fig. 4. Crystals and diffraction pattern. Nice crystals were received with a medium concentration of alcohol and other supplements (A). X-ray diffraction image of DacA (Lmo2120) crystals (B); the highlighted box is shown enlarged (C). The dataset was measured at the EMBL Hamburg Beamline P13 at the PETRA III synchrotron on the DESY campus.

Goe-dac-fig-5.png

Fig. 6. Protein structure of DacA. (A, B) Ribbon representation of DacA in the ATP bound state. (C, D) Surface structure of DacA and the ATP-binding pocket. (E) Magnified view into the ATP-binding pocket


References

Corrigan RM and Gründling A. (2013) Cyclic di-AMP: another second messenger enters the fray. Nat Rev Microbiol. 11(8):513-524

Luo Y and Helmann JD. (2012) Analysis of the role of Bacillus subtilis σ(M) in β-lactam resistance reveals an essential role for c-di-AMP in peptidoglycan homeostasis. Mol Microbiol. 83(3):623-639

Mehne FM, Gunka K, Eilers H, Herzberg C, Kaever V, Stülke J. (2013) Cyclic di-AMP homeostasis in Bacillus subtilis: both lack and high level accumulation of the nucleotide are detrimental for cell growth. J Biol Chem. 288(3):2004-2017

Oppenheimer-Shaanan Y, Wexselblatt E, Katzenhendler J, Yavin E, Ben-Yehuda S. (2011) c-di-AMP reports DNA integrity during sporulation in Bacillus subtilis. EMBO Rep. 12(6):594-601

Witte G, Hartung S, Büttner K, Hopfner KP. (2008) Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. Mol Cell. 30(2):167-178

 

Previous Next